Mytrex Health Technologies, Inc.(TW:4431)
NT$21.40+0.55 (+2.64%)
TW:4431
Mytrex Health Technologies, Inc. financials statements
NT$21.40
At close:+0.55 (+2.64%)
Mytrex Health Technologies, Inc. (4431) Income Statement
Mytrex Health Technologies, Inc. Income Statement
Last quarter (Q2 2026), Mytrex Health Technologies, Inc.'s total revenue was NT$1.06B, an increase of 32.62% from the same quarter last year. In Q2, Mytrex Health Technologies, Inc.'s net income was NT$2.62M. See Mytrex Health Technologies, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 1.94B | NT$ 1.76B | NT$ 1.29B | NT$ 1.47B | NT$ 291.62M | |
| NT$ 218.77M | NT$ 221.55M | NT$ 192.34M | NT$ 239.40M | NT$ 40.14M | |
| NT$ 249.40M | NT$ 298.42M | NT$ 262.90M | NT$ 286.27M | NT$ 55.62M | |
| Depreciation and Amortization | NT$ 37.80M | NT$ 95.47M | NT$ 96.98M | NT$ 106.51M | NT$ 50.60M |
| NT$ 7.17M | NT$ 17.30M | NT$ 45.10M | NT$ 49.89M | NT$ 35.14M | |
| NT$ -30.63M | NT$ -76.86M | NT$ -78.00M | NT$ -51.89M | NT$ -15.46M | |
| NT$ 9.13M | NT$ -7.46M | NT$ 20.82M | NT$ -9.97M | NT$ 1.88M | |
| NT$ -21.50M | NT$ -84.32M | NT$ -57.18M | NT$ -61.86M | NT$ -13.60M | |
| NT$ -16.60M | NT$ -82.38M | NT$ -56.22M | NT$ -91.90M | NT$ -14.01M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ -0.45 | NT$ -2.25 | NT$ -1.54 | NT$ -2.52 | NT$ -0.38 |
| Diluted EPS | NT$ -0.45 | NT$ -2.25 | NT$ -1.54 | NT$ -2.52 | NT$ -0.38 |
| Weighted Average Shares Outstanding | 36.89M | 36.54M | 36.51M | 36.54M | 36.53M |
| Weighted Average Shares Outstanding (Diluted) | 36.89M | 36.61M | 36.54M | 36.54M | 36.53M |
Currency in TWD

